daunorubicin hydrochloride (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the daunorubicin hydrochloride drug offered from Teva Parenteral Medicines, Inc.. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
| NON-PROPRIETARY NAME: | daunorubicin hydrochloride |
| SUBSTANCE NAME: | DAUNORUBICIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2004-04-01 |
| END MARKETING DATE: | 0000-00-00 |
daunorubicin hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | daunorubicin hydrochloride from Teva Parenteral Medicines, Inc. |
| LABELER NAME: | Teva Parenteral Medicines, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2004-04-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0703-5233_7b50db67-621a-4022-a9d1-186683a1a52d |
| PRODUCT NDC: | 0703-5233 |
| APPLICATION NUMBER: | ANDA065035 |
Other DAUNORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
